Genentech Provides Update On Phase Iii Study Of Avastin In Men With Late Stage Prostate Cancer Source: Earth Times Friday 12th March, 2010
SOUTH SAN FRANCISCO, Calif. - (Business Wire) Genentech, Inc., a wholly owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today the topline results of a Phase III trial led by th... ...
